title: Topiramate--add-on drug for partial seizures.
abstract: Topiramate (Topamax-Janssen-Cilag Ltd) is a new drug for the treatment of adults with epilepsy. It is licensed for adjunctive treatment of partial seizures, with or without secondary generalisation, poorly controlled by conventional first-line regimens. Topiramate is the third add-on treatment for epilepsy to be marketed in the last 4 years. Does it have a specific place in the treatment of epilepsy?
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose